Published in Am J Clin Pathol on April 01, 2000
Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol (2003) 1.08
Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol (2013) 1.03
Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth. Am J Pathol (2010) 0.95
Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer. Invest New Drugs (2002) 0.92
Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides. PLoS One (2012) 0.88
A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone. Clin Exp Metastasis (2014) 0.87
Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer (2015) 0.84
The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review. J Cancer Res Clin Oncol (2012) 0.84
Is angiogenesis a hallmark of prostate cancer? Front Oncol (2013) 0.81
Augmented mast cell infiltration and microvessel density in prostate cancer. Contemp Oncol (Pozn) (2013) 0.78
Magnetic fluid hyperthermia inhibits the growth of breast carcinoma and downregulates vascular endothelial growth factor expression. Oncol Lett (2014) 0.77
Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study. Cancer Prev Res (Phila) (2015) 0.76
Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma. J Korean Neurosurg Soc (2015) 0.75
Delineation of prognostic biomarkers in prostate cancer. Nature (2001) 12.25
Should physicians prescribe religious activities? N Engl J Med (2000) 6.73
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79
Religion, spirituality, and medicine. Lancet (1999) 5.58
Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus. J Virol (1976) 3.94
Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology (2008) 3.83
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol (1993) 2.69
Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60
Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet (2001) 2.49
Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology (1994) 2.41
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry (1994) 2.40
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22
Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol (1992) 2.18
Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol (2007) 2.17
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res (1995) 1.98
Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol (1989) 1.98
Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer (1995) 1.93
Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol (2000) 1.91
Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. J Natl Cancer Inst (2000) 1.80
Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol (1992) 1.80
Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol (2000) 1.70
Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J Urol (1996) 1.69
Adrenal myelolipoma. Surgery (1973) 1.66
The ileal ureter neobladder is associated with a high success and a low complication rate. J Urol (1996) 1.62
Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn (2000) 1.58
Urodynamics and the etiology of post-prostatectomy urinary incontinence: the initial Columbia experience. J Urol (1995) 1.53
Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate (1987) 1.53
Clinical management of non-testicular intrascrotal tumors. J Urol (1976) 1.51
Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Urology (1996) 1.50
Urologists on a tightrope: coping with a changing economy. J Urol (1994) 1.47
Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology (2000) 1.45
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol (1999) 1.43
Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. Am J Pathol (2001) 1.40
The mouse prostate reconstitution model of prostate diseases. Prostate (1997) 1.40
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol (2009) 1.40
Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res (1992) 1.37
Stress incontinence: classification and surgical approach. J Urol (1988) 1.35
Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res (1995) 1.33
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate (2001) 1.30
Renal effects of CO2 insufflation: oliguria and acute renal dysfunction in a rat pneumoperitoneum model. Urology (1994) 1.29
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol (1999) 1.29
The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol (1992) 1.29
Apoptosis: molecular control point in toxicity. Toxicol Appl Pharmacol (1994) 1.28
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene (2006) 1.28
The flow rate nomogram: I. Development. J Urol (1979) 1.28
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27
Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol (1999) 1.27
Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem (2000) 1.26
Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer (1997) 1.26
Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. J Urol (2000) 1.22
Effect of mental stress throughout the day on cardiac autonomic control. Biol Psychol (1994) 1.22
Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol (2001) 1.21
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res (1997) 1.21
Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol (1995) 1.20
Hypertension is associated with severe erectile dysfunction. J Urol (2000) 1.19
Heart period variability and psychopathology in urban boys at risk for delinquency. Psychophysiology (1998) 1.19
Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res (2001) 1.18
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol (1999) 1.18
Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study. Health Technol Assess (2012) 1.17
Apoptosis in the rat penis after penile denervation. J Urol (1997) 1.15
Conservative management of renal artery embolus. J Urol (1973) 1.15
Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia (2001) 1.14
A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy. J Urol (2000) 1.14
Cardiac autonomic control and hostility in healthy subjects. Am J Cardiol (1994) 1.13
Supratentorial ependymomas in adult patients. Neurosurgery (1999) 1.13
Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein. Prostate (2000) 1.12
Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology (1999) 1.11
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate Cancer Prostatic Dis (2013) 1.11
Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke (1998) 1.11
Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy. J Urol (1997) 1.11
Health-risk behaviours among adolescent survivors of childhood cancer. Pediatr Blood Cancer (2005) 1.11
Hostility, gender, and cardiac autonomic control. Psychosom Med (2001) 1.11
Effects of strength training on total and regional body composition in older men. J Appl Physiol (1985) (1994) 1.10
Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria. Int J Oncol (2006) 1.10
Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res (2001) 1.10
Spirituality and medical practice: a look at the evidence. Am Fam Physician (2001) 1.09
Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant (2006) 1.09
Urinary continence after radical prostatectomy: the Columbia experience. J Urol (1998) 1.09
Seminal vesicle amyloidosis. Urology (1973) 1.09
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium. Urol Oncol (2011) 1.09